MO01.33 CRESTONE – Clinical Study of REsponse to Seribantumab in Tumors with NEuregulin-1 (NRG1) Fusions – A Phase 2 Study of the anti-HER3 mAb for Advanced or Metastatic Solid Tumors (NCT04383210)

Abstract

Open access

Peer reviewed

D. Spigel, S.N. Waqar, M.E. Burkard, J.J. Lin, Y.K. Chae, M.A. Socinski, S. Gadgeel, K.L. Reckamp, S.M. Leland, D. Plessinger, …

Journal of thoracic oncology, Vol.16(1), pp.S29-S30

01/2021

DOI: 10.1016/j.jtho.2020.10.138

Files and links (1)

url

https://doi.org/10.1016/j.jtho.2020.10.138View

Published (Version of record) Open Access

Title: Subtitle: MO01.33 CRESTONE – Clinical Study of REsponse to Seribantumab in Tumors with NEuregulin-1 (NRG1) Fusions – A Phase 2 Study of the anti-HER3 mAb for Advanced or Metastatic Solid Tumors (NCT04383210)
Creators: D. Spigel - Sarah Cannon
S.N. Waqar - Washington University in St. Louis
M.E. Burkard - University of Wisconsin Carbone Cancer Center
J.J. Lin - Massachusetts General Hospital
Y.K. Chae - Northwestern University
M.A. Socinski - Florida Hospital Cancer Institute
S. Gadgeel - Henry Ford Health System
K.L. Reckamp - Cedars-Sinai Medical Center
S.M. Leland - New York Oncology Hematology
D. Plessinger - New York Oncology Hematology
L. Kunkel - LAK505, Santa Fe, United States
J.R. Bauman - Fox Chase Cancer Center
G. Otterson - The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
B. Halmos - Montefiore Medical Center
S.-H. Ignatius Ou - University of California, Irvine
T. Patil - University of Colorado Denver
Y.Y. Elamin - The University of Texas MD Anderson Cancer Center
E.S. Kim - Levine Cancer Institute
Resource Type: Abstract
Publication Details: Journal of thoracic oncology, Vol.16(1), pp.S29-S30
Publisher: Elsevier Inc
DOI: 10.1016/j.jtho.2020.10.138
ISSN: 1556-0864
eISSN: 1556-1380
Language: English
Date published: 01/2021
Academic Unit: Internal Medicine
Record Identifier: 9984700647002771

3 Record Views